𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibody covalently coupled to liposomes: Specific targeting to cells

✍ Scribed by Barbet, Jacques ;Machy, Patrick ;Leserman, Lee D.


Publisher
Wiley (John Wiley & Sons)
Year
1981
Tongue
English
Weight
896 KB
Volume
16
Category
Article
ISSN
0275-3723

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We have evaluated optimal conditions for coupling monoclonal antibody to small unilamellar lipisomes. Coupling of an IgG~2__a__~ monoclonal anti‐β~2~‐microglobulin antibody, which reacts with human cells, was examined in detail. Liposomes were composed of dipalmitoyl lecithin and cholesterol, and variable quantities of phosphatidylethanolamine substituted with the heterobifunctional cross‐linking reagent N‐hydroxysuccinimidyl 3‐(2‐pyridyldithio) propionate (SPDP). They were reacted with antibody derivatized with the same reagent at a 5‐ to 20‐fold molar excess, and activated by mild reduction. This degree of SPDP modification had no effect on the capacity of the antibody to bind to its target antigen. More than 40% of antibody could be reproducibly bound to liposomes, resulting in the coupling of from 1 to 10 antibody molecules per liposome (mean diameter.580 Å). The coupling reaction did not lead to loss of carboxyfluorescein encapsulated within liposomes. At least 80% of liposomes carried nondenatured antibody, as confirmed by precipitation of liposomes and encapsulated carboxyfluorescein by Staphylococcus aureus, strain Cowan I. The liposome‐coupled antibody retained its immunological specificity: only cells expressing human β~2~‐microglobulin bound liposomes in vitro, and the binding was inhibited by the free antibody in solution. Results with antibodies of different antigenic specificity confirm that the technique can be generally applied.


📜 SIMILAR VOLUMES


Specific thermal ablation of tumor cells
✍ Radu Marches; Pavitra Chakravarty; Inga H. Musselman; Pooja Bajaj; Robert N. Aza 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB

## Abstract CD22 is broadly expressed on human B cell lymphomas. Monoclonal anti‐CD22 antibodies alone, or coupled to toxins, have been used to selectively target these tumors both in SCID mice with xenografted human lymphoma cell lines and in patients with B cell lymphomas. Single‐walled carbon na

Targeting of [111In]biocytin to cultured
✍ Katherine Sheldon; Reuben Baumal; Alexander Marks 📂 Article 📅 1992 🏛 Elsevier Science ⚖ 351 KB

Three monoclonal antibodies (mAb) directed against the human ovarian adenocarcinoma cell line HEY, were substituted with maleimide and covalently bonded to thiolated streptavidin. The conjugates were separated from unreacted reagents by successive affinity chromatography on protein A-Sepharose and i

Specific targeting of adriamycin conjuga
✍ Ruth Adler; Esther Hurwitz; Jack R. Wands; Michael Sela; Daniel Shouval 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Doxorubicin (adriamycin), once considered the treatment of choice for hepatocellular carcinoma (HCC), is known to cause cardiotoxicity and myelotoxicity. To reduce the systemic toxicity of adriamycin by direct delivery of the drug to the tumor site, we established a panel of monoclonal antibodies (M

Targeted transfer of polyethylenimine–av
✍ Urszula Wojda; Jeffery L. Miller 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Here we examine whether attachment of biotinylated antibodies to proteins on the cell surface increases the transfection efficiency of polyethylenimine-avidin-DNA bioconjugate gene transfer. Preliminary experiments were performed to compare avidin endocytosis into cells incubated with biotinylated a

Monoclonal antibody specific to signet r
✍ Uyama, Taro ;Nishikata, Takahito ;Satoh, Noriyuki ;Michibata, Hitoshi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

## Abstract Ascidians are known to accumulate vanadium in their blood cells and have six to nine different types of blood cells. Among these cells, the signet ring cell has been newly identified as the vanadocyte (vanadium‐containing blood cell). We have raised monoclonal antibodies specific to the